Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news
Once-a-Month Osteoporosis Drug Launched in U.K.
|
WEDNESDAY, Sept. 21 (HealthDay News) -- The first once-a-month tablet to treat postmenopausal osteoporosis has been launched in the U.K. Bonviva (ibandronic acid) is a bisphosphonate designed to increase bone density, according to drug makers Roche and GlaxoSmithKline, who collaborated in developing the product. In a statement, the companies said the convenience of having to take just 12 tablets a year may make it easy for women to adhere to therapy, improve their bone health, and reduce the risk of fractures. Adherence to bisphophonates that need to be taken daily or weekly can be a problem due to the need for strict fasting and other dosing requirements, the drug makers said. "Bisphosphonates are the most commonly prescribed treatment for osteoporosis because they are extremely effective at reducing fracture risk and are generally well-tolerated by patients," Dr. Mike Stone, consultant physician, Llandough Hospital, Cardiff, said in prepared statement. "However, for many patients the frustration of having to take them on an empty stomach and then remain upright and avoid eating for a while results in a very low level of patient adherence," he added. "The development of once-monthly oral Bonviva is a great example of where science has met the needs of patients for greater flexibility and convenience whilst also providing physicians with a new treatment option that can help reduce fractures," Stone said. More information The American College of Physicians has more about osteoporosis.
Last Updated: Sept. 21, 2005 |